Systematic Assessment of Treatment Effectiveness for Long-Term Management of Stable Atrial Tachycardia in Inpatient and Outpatient Environments

NCT ID: NCT07239804

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2026-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim is to analyze long-term outcomes in a multicenter observational registry including patients undergoing atrial tachycardia rhythm control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Tachycardia Stroke Mortality Atrial Flutter

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing atrial tachycardia rhythm control

Patients undergoing catheter ablation and/or electrocardioversion for atrial tachycardia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients undergoing atrial tachycardia rhythm control

Exclusion Criteria

Follow-up \<30 days after atrial tachycardia rhythm control
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitätsklinikum Hamburg-Eppendorf

OTHER

Sponsor Role collaborator

Staedtisches Klinikum Karlsruhe

OTHER

Sponsor Role collaborator

Münster University Hospital, Germany

UNKNOWN

Sponsor Role collaborator

Asklepios Klinik St. Georg

UNKNOWN

Sponsor Role collaborator

Evangelical Hospital Düsseldorf

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christian Meyer

Director of the Division of Cardiology, Electrophysiology, Angiology, Intensive Care at the EVK Düsseldorf and Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Meyer, MD, MA

Role: PRINCIPAL_INVESTIGATOR

EVK, Düsseldorf

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

EVK Düsseldorf

Düsseldorf, , Germany

Site Status

Asklepios Hospital St. Georg

Hamburg, , Germany

Site Status

University Hospital Hamburg-Eppendorf

Hamburg, , Germany

Site Status

Municipal Clinical Center Karlsruhe

Karlsruhe, , Germany

Site Status

University Hospital Münster

Münster, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Jungen C, Akbulak R, Kahle AK, Eickholt C, Schaeffer B, Scherschel K, Dinshaw L, Muenkler P, Schleberger R, Nies M, Gunawardene MA, Klatt N, Hartmann J, Merbold L, Jularic M, Willems S, Meyer C. Outcome after tailored catheter ablation of atrial tachycardia using ultra-high-density mapping. J Cardiovasc Electrophysiol. 2020 Oct;31(10):2645-2652. doi: 10.1111/jce.14703. Epub 2020 Aug 11.

Reference Type BACKGROUND
PMID: 32748442 (View on PubMed)

Kahle AK, Jungen C, Scherschel K, Alken FA, Meyer C. Relationship Between Early and Late Recurrences After Catheter Ablation for Atrial Tachycardia in Patients With a History of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2022 Jun;15(6):e010727. doi: 10.1161/CIRCEP.121.010727. Epub 2022 May 27. No abstract available.

Reference Type BACKGROUND
PMID: 35622433 (View on PubMed)

Brachmann J, Lewalter T, Kuck KH, Andresen D, Willems S, Spitzer SG, Straube F, Schumacher B, Eckardt L, Danilovic D, Thomas D, Hochadel M, Senges J. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry. Eur Heart J. 2017 May 1;38(17):1317-1326. doi: 10.1093/eurheartj/ehx101.

Reference Type BACKGROUND
PMID: 28329395 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SATELLITE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Outcome of SVT in Children Admitted to AUCH
NCT07143591 NOT_YET_RECRUITING